Size and dynamics of order-of-entry effects in pharmaceutical markets

In anticipation of long-run competitive advantages, pharmaceutical companies often try to enter new markets earlier than their competitors.

Short summary of the main findings

As it stands, pharmaceutical companies, planning the date of a new launch, know that order-of-entry effects exist, but they do not have the information necessary to optimize the launch process. The findings of this study can be used for this purpose, because they provide a detailed description of order-of-entry effects in the largest pharmaceutical markets worldwide. The major finding is as follows: Early entrant advantages are still present for the sixth entrant to a new market. The advantages first build up after the launch, then slowly decline over time, and eventually die out after...

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands